Literature DB >> 20114152

Ear, nose and throat manifestation of viral systemic infections in pediatric patients.

N Mansi1, V de Maio, A della Volpe, G Ripa, L Malafronte, C de Filippis.   

Abstract

OBJECTIVE/
METHODS: An exhaustive review of literature was performed to investigate available data and evidences regarding pediatric otolaryngologic manifestations of viral systemic infections. RESULTS/
CONCLUSIONS: Modern otolaryngologists should be familiar with viral systemic infections since many have head and neck manifestations. Cooperation between otolaryngologist, paediatrician and virologist can be considered and excellent tool in diagnosis and treatment of these diseases in particular when complications occur. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20114152      PMCID: PMC7119457          DOI: 10.1016/S0165-5876(09)70006-0

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  38 in total

1.  Systemic cidofovir in papillomatosis.

Authors:  I Van Valckenborgh; W Wellens; K De Boeck; R Snoeck; E De Clercq; L Feenstra
Journal:  Clin Infect Dis       Date:  2001-01-23       Impact factor: 9.079

Review 2.  [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].

Authors:  S W Wassilew
Journal:  MMW Fortschr Med       Date:  2006

3.  Histopathologic effects of cidofovir on cartilage.

Authors:  Jeffrey H Spiegel; Jennifer G Andrus; Catherine M Stefanato; Timothy Heeren
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

4.  Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

Authors:  R Snoeck; W Wellens; C Desloovere; M Van Ranst; L Naesens; E De Clercq; L Feenstra
Journal:  J Med Virol       Date:  1998-03       Impact factor: 2.327

5.  Inner ear and facial nerve complications of acute otitis media with focus on bacteriology and virology.

Authors:  Dag Hydén; Britt Akerlind; Markus Peebo
Journal:  Acta Otolaryngol       Date:  2006-05       Impact factor: 1.494

6.  Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study.

Authors:  D R Endres; N M Bauman; D Burke; R J Smith
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-04       Impact factor: 1.547

7.  Can mumps vaccine induce remission in recurrent respiratory papilloma?

Authors:  Nigel R T Pashley
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

8.  Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.

Authors:  S B Boppana; R F Pass; W J Britt; S Stagno; C A Alford
Journal:  Pediatr Infect Dis J       Date:  1992-02       Impact factor: 2.129

Review 9.  Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis.

Authors:  M A Avidano; G T Singleton
Journal:  Otolaryngol Head Neck Surg       Date:  1995-02       Impact factor: 5.591

10.  Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit.

Authors:  Kam Lun Hon; Erica Leung; Erica Hung; Julian Tang; Chung Mo Chow; Ting Fan Leung; Kam Lau Cheung; Pak Cheung Ng
Journal:  Pediatr Pulmonol       Date:  2008-03
View more
  1 in total

Review 1.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.